Affiliation:
1. Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON
Abstract
Abstract
Two novel oral anticoagulants, dabigatran and rivaroxaban, have recently been approved. They differ in many ways from warfarin, including rapid onset of action, shorter half-life, fewer drug-drug interactions, lack of need for monitoring, and no need for titration or dose adjustments. These novel agents represent a landmark shift in anticoagulant care; however, many aspects of their use will be unfamiliar to practicing clinicians, despite the imminent widespread use of these agents in the community. The management of these anticoagulants when transitioning from or back to warfarin, around surgery or in case of major hemorrhage, requires knowledge of their pharmacokinetics and mechanism of action. Unfortunately, there is a limited evidence base to inform decisions around management of these agents. We present our practice in these settings supported, where available, with literature evidence.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference47 articles.
1. U.S. Food and Drug Administration
FDA News Release: FDA approves Pradaxa to prevent stroke in people with atrial fibrillation.
Accessed October 9, 2011
www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230241.htm
2. Dabigatran versus warfarin in patients with atrial fibrillation.;Connolly;N Engl J Med,2009
3. European Medicines Agency
Public assessment report for Pradaxa.
Accessed October 9, 2011
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000829/WC500041060.pdf
4. Dabigatran versus warfarin in the treatment of acute venous thromboembolism.;Schulman;N Engl J Med,2009
5. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.;Wann;J Am Coll Cardiol,2011
Cited by
215 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献